Ascendis Pharma Endocrinology Inc

CA · United States · Reporting entity ID 100000941823

Total reported 2019–2025

$22.9M

#291 of 2,960 reporting companies — 0% of all reported industry payments

$4.78M in general payments across 20,931 records, plus $18.2M in research funding across 5,386 records.

How it breaks down

General payments $4,784,129

Research funding $18,154,305

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.